FDA inspection
Abryl Laboratories Private Limited: FDA inspection ending Nov 20, 2023
FDA inspection 1223096 · Official Action Indicated (OAI) · Dera Bassi
Key facts
| Inspection ID | 1223096 |
|---|---|
| Firm | Abryl Laboratories Private Limited |
| FEI number | 3015793804 |
| Address | Mohali |
| City | Dera Bassi |
| Fiscal year | 2024 |
| Inspection end date | Nov 20, 2023 |
| Classification | Official Action Indicated (OAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data